231 related articles for article (PubMed ID: 22176646)
1. Glioblastoma biomarkers from bench to bedside: advances and challenges.
Farias-Eisner G; Bank AM; Hwang BY; Appelboom G; Piazza MA; Bruce SS; Sander Connolly E
Br J Neurosurg; 2012 Apr; 26(2):189-94. PubMed ID: 22176646
[TBL] [Abstract][Full Text] [Related]
2. The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme.
Bambury RM; Morris PG
Expert Rev Anticancer Ther; 2014 Aug; 14(8):955-64. PubMed ID: 24814143
[TBL] [Abstract][Full Text] [Related]
3. Adult Glioblastoma.
Alexander BM; Cloughesy TF
J Clin Oncol; 2017 Jul; 35(21):2402-2409. PubMed ID: 28640706
[TBL] [Abstract][Full Text] [Related]
4. Advances and challenges in the treatment of glioblastoma: a clinician's perspective.
Mrugala MM
Discov Med; 2013 Apr; 15(83):221-30. PubMed ID: 23636139
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients.
Oblinger JL; Pearl DK; Boardman CL; Saqr H; Prior TW; Scheithauer BW; Jenkins RB; Burger PC; Yates AJ
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):410-8. PubMed ID: 16866986
[TBL] [Abstract][Full Text] [Related]
6. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
Kesari S
Semin Oncol; 2011 Dec; 38 Suppl 4():S2-10. PubMed ID: 22078644
[TBL] [Abstract][Full Text] [Related]
7. Emerging treatment strategies for glioblastoma multiforme.
Carlsson SK; Brothers SP; Wahlestedt C
EMBO Mol Med; 2014 Nov; 6(11):1359-70. PubMed ID: 25312641
[TBL] [Abstract][Full Text] [Related]
8. The EGFRvIII variant in glioblastoma multiforme.
Gan HK; Kaye AH; Luwor RB
J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
[TBL] [Abstract][Full Text] [Related]
9. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers and therapeutic advances in glioblastoma multiforme.
Sasmita AO; Wong YP; Ling APK
Asia Pac J Clin Oncol; 2018 Feb; 14(1):40-51. PubMed ID: 28840962
[TBL] [Abstract][Full Text] [Related]
11. Necroptosis: a novel therapeutic target for glioblastoma.
Jiang YG; Peng Y; Koussougbo KS
Med Hypotheses; 2011 Mar; 76(3):350-2. PubMed ID: 21075544
[TBL] [Abstract][Full Text] [Related]
12. Towards developing biomarkers for glioblastoma multiforme: a proteomics view.
Jayaram S; Gupta MK; Polisetty RV; Cho WC; Sirdeshmukh R
Expert Rev Proteomics; 2014 Oct; 11(5):621-39. PubMed ID: 25115191
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways and potential therapeutic targets in glioblastoma multiforme.
Wardak Z; Choe KS
Expert Rev Anticancer Ther; 2013 Nov; 13(11):1307-18. PubMed ID: 24168050
[TBL] [Abstract][Full Text] [Related]
14. Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients.
Carlsson A; Persson O; Ingvarsson J; Widegren B; Salford L; Borrebaeck CA; Wingren C
Proteomics Clin Appl; 2010 Jul; 4(6-7):591-602. PubMed ID: 21137077
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of glioblastoma multiforme.
Nicolaidis S
Metabolism; 2015 Mar; 64(3 Suppl 1):S22-7. PubMed ID: 25468141
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
[TBL] [Abstract][Full Text] [Related]
17. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma multiforme: a review of therapeutic targets.
Kanu OO; Mehta A; Di C; Lin N; Bortoff K; Bigner DD; Yan H; Adamson DC
Expert Opin Ther Targets; 2009 Jun; 13(6):701-18. PubMed ID: 19409033
[TBL] [Abstract][Full Text] [Related]
19. Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.
Tabone T; Abuhusain HJ; Nowak AK; ; Erber WN; McDonald KL
J Clin Pathol; 2014 Jul; 67(7):550-5. PubMed ID: 24695838
[TBL] [Abstract][Full Text] [Related]
20. Improve Glioblastoma Multiforme Prognosis Prediction by Using Feature Selection and Multiple Kernel Learning.
Zhang Y; Li A; Peng C; Wang M
IEEE/ACM Trans Comput Biol Bioinform; 2016; 13(5):825-835. PubMed ID: 27071189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]